Medicare Advantage's Membership-for-Margin Reset: The 2027 Landscape File Shows Insurers Trading Enrollment for Margin

Medicare Advantage's Membership-for-Margin Reset: The 2027 Landscape File Shows Insurers Trading Enrollment for Margin

New finding (2026-10-05). CMS released its 2027 Medicare Advantage landscape file on September 29, 2026, and the sector-wide picture confirms what executives previewed all summer: for the second straight year, the large MA insurers are deliberately sacrificing membership to rebuild margins after years of utilization overshoot. The headline numbers look stable — total MA plans slip only from 5,553 to 5,532 — but Healthcare Dive's analysis of the file shows that "obfuscates significant turmoil under the surface, as major insurers broadly reduced their plans while increasing cost sharing for enrollees in the plans that remain."

The cuts, insurer by insurer (per Stephens data cited by Healthcare Dive)

• Plan counts: every major insurer pared back individual MA plans — Centene ~3,000 fewer unique plans, Humana ~2,400, UnitedHealthcare ~690, Elevance ~150.
• County exits: Centene is departing 344 counties, CVS 103, UnitedHealthcare 63, Elevance 56. Humana is the outlier, adding 39 counties.
• Members affected: at least 1 million seniors must switch plans for 2027 — Humana expects its exits to affect ~600,000 members, UnitedHealthcare's ~390,000 (company spokesperson to Bloomberg, Oct 1). For context, Johns Hopkins research found nearly 3 million seniors were forced to find new MA coverage for 2026.
• Enrollment: insurer projections put 2027 MA enrollment at ~34 million, down about 2 million — which "could mean that MA would account for less than half of total Medicare population for the first time since 2023."

J.P. Morgan's Lisa Gill: "while the exact magnitude remains somewhat unclear, we think this does point to most [MA companies] trimming their footprints and creating disruption in 2027 [enrollment period]."

How the margin math actually works

The repricing is engineered through cost-sharing, not headline premiums. CMS touted that weighted MA premiums will fall more than 16% (from $14.37 to $12.00/month), but Healthcare Dive notes "that calculation includes lower overall premiums for SNP plans, so it underestimates premium changes for the general enrollment MA population" — MA-PD premiums are rising several dollars on average, partly because insurers cut $0-premium plans. The real lever: "Seniors may not see a larger upfront bill for insurance next year but will likely have to pay a higher portion of their medical costs when they receive healthcare."

Meanwhile the plan mix is shifting toward the profitable cohorts: chronic-condition SNPs grow from 548 to 744 plans, because they "generate higher per-enrollee margins than other MA plans."

The market's verdict on the strategy

Investors are rewarding the discipline, not punishing the exits: Humana trades at the 91.3rd percentile of its 52-week range with Q2 EPS of $7.61 beating a $6.22 consensus (/markets/HUM/2026/10/05), and Centene is up 53.1% YTD after its Q2 adjusted EPS of $2.51 crushed a $0.89 estimate (/markets/CNC/2026/10/05). The divergence between the public narrative ("insurers are abandoning seniors," "MA is broken") and the segment economics (deliberate margin engineering, priced-in and celebrated) is the sharpest it has been in two cycles of tracking this sector.

What it means

The anger from displaced enrollees is real and politically volatile — the Healthcare Dive piece flags that instability "doesn't bode well for the Trump administration, which is wary about seniors losing benefits — especially during a midterm election year." But the economics are a choice, not an accident: with the final 2027 CMS rate notice landing at ~2.48% (after a January proposal of just 0.09% that briefly sent UNH down ~30%), insurers are pricing MA for profitability, culling unprofitable plans and counties, and shifting mix toward higher-margin SNPs¹. Watch the enrollment recapture question and the Q3 MCR prints: UnitedHealth: Stars Step-Down (81%→68%) Into Tomorrow's Q3 MCR-Guide Test, Humana: The Stars Reversal — 41%→93% in 4+ Star Plans, a $3–4.8B 2028 Bonus Recovery, and a 52-Week-High Repricing, and Medicare Advantage Star Ratings: 2027 Release Repriced the Sector — Humana's Reversal, the Giants' Step-Down, Alignment's Suit Threat all feed this subject.